PRESS RELEASE
PRESS RELEASE: Inteliquet™ Announces Presbyterian Healthcare Services to Join Consortium to Drive Better Patient Matching in Clinical Trials
“Presbyterian has earned a reputation for investing in teams and a process that in turn take the time to understand and serve patients as individuals.” – Dr. Tandy Tipps, Senior Vice President, Healthcare Organizations at Inteliquet™
On June 23, 2021, Inteliquet announced that Presbyterian Healthcare Services of Albuquerque, New Mexico will join Inteliquet’s Cancer Center Research Consortium for their comprehensive oncological care and leading-edge clinical research.
Presbyterian decided to become part of the Consortium to leverage AI-powered data to securely and quickly identify eligible patients for the right trials. The experts at Presbyterian Cancer Care are dedicated to delivering compassionate, individualized care for their patients, and OncWeb™ provides them with the ability to scale and remain patient-centric, regardless of size, type, and therapeutic focus.
The Consortium provides physicians with the de-identified data needed to conduct detailed patient treatment comparisons with the information that matters most to each individual, so they can make more informed and precise care decisions. Norbert Topf M.D. of Presbyterian sees the Consortium as an opportunity for oncology professionals at the cancer center to collaborate with technologists, surgical oncologists, and radiation oncologists on a greater scale, enhancing treatment plans for every patient.
